Bharat Biotech's US partner Ocugen has said that it had asked the United States (US) authorities for emergency use authorization for the Covid-19 vaccine Covaxin in the US, for children in the age group of 2-18 years. While talking about the merits of using Covaxin as a covid-19 vaccination for children, Bharat Biotech's clinical lead for Covid-19 vaccines, Dr Raches Ella on his Twitter handle writes, "We are pleased to announce our EUA filing to the US-FDA through our partners- Ocugen."

Bharat Biotech's US partner Ocugen has said that it had asked the United States (US) authorities for emergency use authorization for the Covid-19 vaccine Covaxin in the US, for children in the age group of 2-18 years. While talking about the merits of using Covaxin as a covid-19 vaccination for children, Bharat Biotech's clinical lead for Covid-19 vaccines, Dr Raches Ella on his Twitter handle writes, "We are pleased to announce our EUA filing to the US-FDA through our partners- Ocugen."